Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

SELL
$36.12 - $47.5 $72 - $95
-2 Reduced 33.33%
4 $0
Q1 2023

May 10, 2023

BUY
$35.53 - $43.38 $142 - $173
4 Added 200.0%
6 $0
Q4 2022

Feb 01, 2023

SELL
$38.19 - $57.45 $38 - $57
-1 Reduced 33.33%
2 $0
Q3 2022

Nov 03, 2022

SELL
$51.24 - $58.89 $51 - $58
-1 Reduced 25.0%
3 $0
Q2 2022

Aug 09, 2022

SELL
$51.49 - $81.64 $51 - $81
-1 Reduced 20.0%
4 $0
Q1 2022

Apr 22, 2022

BUY
$60.03 - $76.49 $300 - $382
5 New
5 $0

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Disciplined Investments, LLC Portfolio

Follow Disciplined Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Investments, LLC with notifications on news.